To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is part of a Comprehensive Cancer Center designated by the National Cancer Institute. It is a major affiliate of Harvard Medical School and is located in the Longwood Medical Area in Boston, Massachusetts.
The origins of Dana-Farber date back to 1947 when Sidney Farber, MD, founded Children's Cancer Research Foundation. In 1974, it became known as the Sidney Farber Cancer Institute in honor of its founder. The support of the Charles A. Dana Foundation was acknowledged by incorporating Dana's name in 1983.
Dana-Farber employs about 3,150 people. There are more than 185,000 adult and pediatric patient visits a year, and it is involved in some 200 clinical trials. It is internationally known for its research and clinical excellence. Dana-Farber is a member of the Multiple Myeloma Research Consortium.
In addition to being a principal teaching affiliate of Harvard Medical School, Dana-Farber is also a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a federally designated comprehensive cancer center. Providing advanced training in cancer treatment and research for an international faculty, Dana-Farber conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School and the Partners HealthCare System, including Brigham and Women's Hospital, Children's Hospital, and Massachusetts General Hospital.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and private foundations and individuals contributions. The Jimmy Fund is the principal charity of the Institute named for one of its child patients. The Boston Red Sox adopted the Jimmy Fund as its official charity in 1953 and continues to prominently sponsor the charity.
Additional recommended knowledge
History of advances in cancer care and research at Dana-Farber
Dana-Farber has a long history of breakthrough discoveries in cancer care and research.
Care for adults with cancer
The Dana-Farber/Brigham and Women's Cancer Center is a collaboration between Dana-Farber Cancer Institute and Brigham and Women's Hospital to care for adults with cancer. Dana-Farber provides outpatient services, while inpatient care is provided by Brigham and Women's Hospital.
Together with Massachusetts General Hospital, the adult oncology care at these three institutions comprise Dana-Farber/Partners Cancer Care, which offers access to the comprehensive services of two of the nation's finest general hospitals, and to an exceptionally large number of new treatments through clinical trials.
The Dana-Farber/Brigham and Women's Cancer Center cares for adult patients in 12 specialized centers, each devoted to helping people fight a different type of cancer. This coordinated arrangement makes it possible for many people to see all of their specialists in a single visit. The medical staff works as a team to provide expert evaluation and the most advanced care possible.
Care for children with cancer
Dana-Farber/Children's Hospital Cancer Care (DF/CHCC) is a 60-year-old partnership between Children's Hospital Boston and Dana-Farber Cancer Institute that delivers comprehensive care to children with and survivors of all types of childhood cancers. DF/CHCC specialists are actively involved in pediatric cancer research and use the latest clinical techniques to improve outcomes and quality of life. This includes 13 specialty areas.
Awards and Recognition
As of 2007, the Dana-Farber Cancer Institute was ranked as the fifth best cancer hospital in the United States by U.S. News & World Report.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dana-Farber_Cancer_Institute". A list of authors is available in Wikipedia.|